AstraZeneca PLC News
Alnylam's 5th Drug Launches in July, Disrupting Commercial Landscape
A little competition can greatly benefit patients. Shareholders may have a more difficult path to navigate.
Roche Shows Interest in This Small-Cap Biotech. Should You?
An emerging therapeutic area continues to draw interest from large drugmakers.
Cramer's Mad Money Recap 4/20: Netflix, Disney, Tesla
What works? Jim Cramer says to invest in companies that make things, at a profit, and return some of those profits to shareholders while maintaining a reasonable share price for its growth rate.
Novartis and Roche Have Expensive Drugs That Scare Away Competitors
A brief snapshot of some medical breakthroughs that are among the costliest in the world.
Amazon, GameStop, Jefferies, Covid Concerns and Stock Markets - Five Things You Must Know
Stock futures slip lower as Covid worries and inflation concerns come into focus; AstraZeneca gets FDA nod for its antibody treatment; Jefferies sends bankers home after NY Covid outbreak; Amazon hit with record $1.3 billion fine in Italy and GameStop unveils a wider third quarter loss and details of a new SEC subpoena.
GameStop Stock Surges On Plans For 4-For-1 Stock Split
GameStop will pay a three-share dividend to investors on July 21, with the stock trading on a split-adjusted basis the following day.
Samsung Forecasts Best Quarterly Profits In Four Years, Boosting US Chip Stocks
Chipmakers Intel and Nvidia got a boost Thursday after Samsung Electronic forecast its strongest quarterly profits in four years.
Seagen Stock Leaps On Report Of $40 Billion Takeover By Merck & Co.
Merck is reportedly eying cancer drug specialists Seagen as it looks to replace revenue from its Keytruda blockbuster, which loses patent exclusivity in 2028.
Microsoft Supports Abortion Access But Is Silent on Data Privacy
The software giant hasn't said it will protect user data in wake of Supreme Court ruling overturning Roe.